Open AccessFirst case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B
Author(s) -
Hasnain Md. Golam,
Ghosh Prakash,
Sharafat Sonin Md. Shadab Ibn,
Baker James,
Mondal Dinesh
Publication year - 2014
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.130
Subject(s) - medicine , visceral leishmaniasis , coinfection , tuberculosis , amphotericin b , drug , virology , pharmacology , immunology , human immunodeficiency virus (hiv) , leishmaniasis , antifungal , pathology , dermatology
Key Clinical Message Successful management of cases with visceral leishmaniasis ( VL ) and tuberculosis is a challenge for clinicians, because a guideline for that is currently unavailable. We report the first case in Bangladesh who developed VL during her treatment for pulmonary tuberculosis and was treated successfully with multidose liposomal amhptericin B for VL .